UNH vs ABT
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Abbott Laboratories, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | ABT |
|---|---|---|
| Price | $418.09 | $103.70 |
| Market cap | $375.28B | $179.44B |
| P/E ratio | 26.9 | 38.6 |
| ROE | 15.77% | — |
| Profit margin | 3.53% | 9.75% |
| Revenue growth | -0.40% | 14.50% |
| Dividend yield | 2.22% | 2.43% |
| Beta | 0.61 | 0.58 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs ABT in plain English
- UNH is the bigger company — about 2.1× the market cap of ABT.
- UNH is cheaper on earnings (P/E 26.9 vs 38.6).
- ABT is growing revenue faster (14% vs -0%).
- ABT has the higher dividend yield (2.43% vs 2.22%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
ABT return calculator
See what $1,000 in Abbott Laboratories would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.